AIDS & Diarrhea treatment
STUDY DESIGN Randomized controlled clinical trial (n = 69).
ā¢ The experimental group - 46 patients (19 women and 27 men),
ā¢ a traditional therapy of diarrheal and intoxication syndromes
was conducted as well as two 2-week courses of Enterosgel: the
first - along with start of HAART therapy (within the first two
weeks of HAART); the second - 1.5 months after the start of
HAART (HAART lasting 7 and 8 weeks), if no adverse reactions
(AR) occurred. With the development of AR (diarrhea, nausea,
vomiting, rash, intoxication syndrome) the second course of
Enterosgel was assigned from the onset of AR. Enterosgel was
administered at a dose of one tablespoon 3 times a day 2 hours
after meal.
ā¢ Control group ā 23 patients (7 women and 16 man) were only
under HAART and traditional therapy.
ā¢ A term of monitoring was two months.
Yurchenko, A.V. et al. APPLICATION OF ENTEROSGEL ENTEROSORBENT FOR
TREATMENT OF INTOXICATION AND DIARRHEA SYNDROMES IN PATIENTS
WITH AIDS DURING ANTIRETROVIRAL THERAPY. - Modern drugs and
technologies. - ā 7 (63) 2009.